Rapid risk assessment: Severe respiratory disease associated with a novel influenza A virus, A(H7N9) China
On 31 March 2013, the Chinese authorities announced the identification of a novel influenza A virus, A(H7N9), in three seriously ill people from two provinces presenting with respiratory infections. So far, no epidemiological link has been identified between those three patients. When testing for the influenza virus, the Chinese Center for Disease Control and Prevention identified genes from both A(H7N9) and A(H9N2) viruses, thus indicating a novel reassortant avian influenza A virus. In its initial assessment of the situation, the ECDC rapid risk assessment concludes that the risk of the spread of the virus in Europe can be considered low at this stage.
Rapid risk assessment: Outbreak of yellow fever in Brazil, Third update.
16 Mar 2018 - In September 2017, the Ministry of Health in Brazil declared the end of the 2016–2017 yellow fever outbreak in the country. The upsurge of human cases since December 2017 and the continuous non-human primate epizootics since September 2017 indicate a continued or resumed increase in yellow fever virus circulation in Brazil. Since January 2018, most of the yellow fever cases have been reported from São Paulo, Rio de Janeiro and Minas Gerais states.
Rapid risk assessment: Outbreak of yellow fever in Brazil, Second update
18 Jan 2018 - This publication assesses the risk to EU/EEA countries and citizens associated with the ongoing outbreak of yellow fever in Brazil. This is the second update of a rapid risk assessment originally produced on 25 January 2017 and updated on 13 April 2017.
Joint Rapid Outbreak Assessment: Multi-country outbreak of Salmonella Agona infections linked to infant formula
17 Jan 2018 - This document provides an assessment of the public health risk associated with a multi-country outbreak of Salmonella Agona associated with consumption of potentially contaminated infant formula from France.